Burkitt t(8;14)(q24;q32) and cryptic deletion in a CLL patient: report of a case and review of literature
- 1 April 2006
- journal article
- case report
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 166 (1) , 12-21
- https://doi.org/10.1016/j.cancergencyto.2005.08.025
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Molecular genetics and its clinical relevanceHematology/Oncology Clinics of North America, 2004
- Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B‐cell chronic lymphocytic leukaemiaBritish Journal of Haematology, 2003
- Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factorsBlood, 2002
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Occurrence of both t(1;19) and t(8;14) in a Patient with Chronic Lymphocytic LeukemiaExperimental and Molecular Pathology, 1999
- Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysisJournal of Molecular Medicine, 1999
- Prognostic Subgroups in B-Cell Chronic Lymphocytic Leukemia Defined by Specific Chromosomal AbnormalitiesNew England Journal of Medicine, 1990
- Consistency of chromosomal aberrations in chronic B-lymphocytic leukemia. A longitudinal cytogenetic study of 41 patientsCancer, 1988
- There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomasBlood, 1985
- Karyotype peculiarities of malignant lymphomasHuman Genetics, 1977